Senseonics (NYSE:SENS) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Senseonics (NYSE:SENS) in a research report report published on Thursday. The brokerage issued a sell rating on the stock.

Separately, HC Wainwright reaffirmed a “buy” rating and set a $2.00 target price on shares of Senseonics in a report on Friday, November 15th.

Senseonics Stock Performance

Shares of SENS opened at $0.59 on Thursday. The company has a debt-to-equity ratio of 59.17, a current ratio of 2.47 and a quick ratio of 2.38. The firm’s 50 day moving average is $0.35 and its 200-day moving average is $0.38. Senseonics has a 12-month low of $0.25 and a 12-month high of $0.75. The stock has a market capitalization of $348.86 million, a P/E ratio of -4.51 and a beta of 0.77.

Insider Activity at Senseonics

In related news, CFO Frederick T. Sullivan bought 124,933 shares of Senseonics stock in a transaction that occurred on Thursday, December 12th. The stock was purchased at an average cost of $0.38 per share, for a total transaction of $47,474.54. Following the acquisition, the chief financial officer now owns 2,478,844 shares in the company, valued at $941,960.72. This trade represents a 5.31 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Timothy T. Goodnow bought 315,000 shares of the firm’s stock in a transaction on Tuesday, December 10th. The shares were bought at an average cost of $0.31 per share, with a total value of $97,650.00. Following the transaction, the chief executive officer now directly owns 11,310,355 shares of the company’s stock, valued at approximately $3,506,210.05. This trade represents a 2.86 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 3.60% of the company’s stock.

Institutional Investors Weigh In On Senseonics

Hedge funds have recently bought and sold shares of the company. FMR LLC increased its stake in shares of Senseonics by 48,267.2% in the third quarter. FMR LLC now owns 168,318 shares of the company’s stock worth $59,000 after purchasing an additional 167,970 shares during the period. GSA Capital Partners LLP acquired a new stake in Senseonics in the 3rd quarter valued at approximately $117,000. Cubist Systematic Strategies LLC increased its position in Senseonics by 25.9% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 415,404 shares of the company’s stock worth $166,000 after buying an additional 85,501 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Senseonics by 3.2% during the third quarter. Geode Capital Management LLC now owns 5,838,396 shares of the company’s stock worth $2,042,000 after buying an additional 179,103 shares during the last quarter. Finally, Symmetry Partners LLC bought a new stake in shares of Senseonics in the third quarter valued at approximately $164,000. 12.36% of the stock is currently owned by institutional investors.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.